Anhedonia in substance use disorders: A systematic review of its nature, course and clinical correlates

  title={Anhedonia in substance use disorders: A systematic review of its nature, course and clinical correlates},
  author={Joshua B. B. Garfield and Daniel I Lubman and Murat Y{\"u}cel},
  journal={Australian \& New Zealand Journal of Psychiatry},
  pages={36 - 51}
Objective: There is growing evidence that anhedonia is a commonly experienced symptom among substance-using populations. This systematic review synthesises findings across a range of substances to address questions regarding the time course of anhedonia, how anhedonia relates to other symptoms of substance dependence and whether it is similarly prevalent across all addictive drugs. Method: A literature search was conducted on PubMed, PsycINFO and MEDLINE, yielding 32 studies that used self… 
Addiction, Anhedonia, and Comorbid Mood Disorder. A Narrative Review
Anhedonia is associated with substance use disorders, and their severity is especially prominent in DUS with comorbid depression, and tends to impact DUS treatment outcome negatively.
Possible New Symptoms of Tobacco Withdrawal II: Anhedonia-A Systematic Review.
Anticipatory anhedonia appears to be a symptom of tobacco withdrawal and should be added to tobacco withdrawal checklists and diagnostic criteria, and it is unclear if abstinence increases consummatory or reward learning-based anhedonian.
Assessment of Anhedonia in Adults With and Without Mental Illness: A Systematic Review and Meta-analysis
The findings of this meta-analysis indicate that the severity of anhedonia may differ across disorders associated withAnhedonia, and this findings have implications for psychiatric taxonomy development, where dimensional approaches are gaining attention.
Anhedonia in clinical and non-clinical populations - An exploratory meta-analysis of studies using the Snaith-Hamilton Pleasure Scale
The results indicate that the severity of anhedonia differs across disorders that have been associated with anhedonian symptoms, and may instead reflect a decrease in projected enjoyment of only a minority of life’s many rewards.
Effect of vortioxetine in subjects with major depressive and alcohol use disorders: a 6-month retrospective analysis
Given its effectiveness on mood, cognition, and functioning, its good safety and tolerability profile, and low potential for abuse, vortioxetine could represent a valid pharmacological intervention in MDD + AUD patients as part of an integrated therapeutic-rehabilitation program.
Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.
This chapter discusses potential mechanisms that have implications on psychotherapeutic approaches including induced neuroplasticity, alterations in brain network connectivity, reward and emotion processing, social connectedness, insight, and mystical experiences, and outlines considerations and approaches that leverage these mechanisms in order to optimize the therapeutic embedding.
Cognitive-behavioral therapies for depression and substance use disorders: An overview of traditional, third-wave, and transdiagnostic approaches
By targeting shared cognitive-affective processes underlying SUD-depression, transdiagnostic treatment models have the potential to offer a novel clinical approach to treating this difficult-to-treat comorbidity and relevant, co-occurring psychiatric disturbances, such as posttraumatic stress.


Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options
Treating anhedonia in detoxified alcohol-dependent subjects could be critical in terms of relapse prevention strategies, given its strong relationship with craving.
The Assessment of Post-Detoxification Anhedonia: Influence of Clinical and Psychosocial Variables
In a sample of 70 patients manifesting substance dependence without severe comorbidity, anhedonia appears as a psychopathological entity independent from other clinical and psychosocial features of treated addicts.
Predictors of psychosis severity in individuals with primary stimulant addictions.
Anhedonia associated with stimulant use and dependence in a population-based sample of American adults.
Lifetime anhedonia was more prevalent among respondents who initiated use but did not eventually progress to dependence in comparison with individuals who never once used a stimulant drug, and was consistent across amphetamine- and cocaine-related outcomes.
Temperament and Character Inventory Dimensions and Anhedonia in Detoxified Substance-Dependent Subjects
The possibility that difficulty in experiencing pleasure in psychiatric disorders can lead to the use of psychoactive substances in an attempt to decrease anhedonia, is extended to subjects without psychiatric disorders who may try substances to counterbalance a tonic state of anhedonian.
Effects of anhedonia on days to relapse among smokers with a history of depression: a brief report.
Investigation of the relation between anhedonia and relapse latency among MDD history smokers following a brief smoking cessation workshop suggests thatAnhedonia may constitute a proximal risk factor identifying depressive history smokers more likely to relapse to smoking.
Alcohol Protracted Withdrawal Syndrome: The Role of Anhedonia
The results of this study suggest the relevance of protracted withdrawal well beyond the limited period following the abrupt cessation of alcohol intake and the clinical dimension of anhedonia cannot be separated from the other behavioral symptoms of withdrawal.
Anhedonia and relapse in alcoholism
Relations between anhedonia and smoking motivation.
Findings elucidate anhedonia's link with smoking relapse and could be useful for developing cessation interventions for anhedonic smokers.